Fred M. Powell is President & CFO +1 at ANTARES PHARMA, INC. (ATRS). They have made 9 open-market trades across 3 companies since 2008, most recently 2025-11-13.
CIK 0001331339
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
9 open-market purchases totalling $882K since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRS | BUY | 2020-11-12 | 2020-11-16 | $2.85 | $47K | +5.8% | +32.5% | +54.6% |
| ATRS | BUY | 2017-06-09 | 2017-06-13 | $2.79 | $363K | +7.0% | +9.0% | +1.3% |
| ATRS | BUY | 2016-12-09 | 2016-12-12 | $2.03 | $406K | +9.4% | +12.3% | +22.7% |
| CPXX | BUY | 2015-10-05 | 2015-10-05 | $1.78 | $24K | N/A | N/A | N/A |
| CPXX | BUY | 2014-11-18 | 2014-11-18 | $2.20 | $13K | N/A | N/A | N/A |
| CPXX | BUY | 2014-05-15 | 2014-05-16 | $2.50 | $6K | N/A | N/A | N/A |
| CPXX | BUY | 2013-12-17 | 2013-12-17 | $3.50 | $9K | N/A | N/A | N/A |
| BJGP | BUY | 2009-08-13 | 2009-08-17 | $3.98 | $4K | N/A | N/A | N/A |
| BJGP | BUY | 2008-05-22 | 2008-05-27 | $6.75 | $10K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.